| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MMSI | Common Stock, No Par Value | Award | $0 | +27.2K | +2.72% | $0.00 | 1.03M | Feb 28, 2023 | Direct | F1 |
| transaction | MMSI | Common Stock, No Par Value | Tax liability | -$849K | -12K | -1.17% | $70.58 | 1.01M | Feb 28, 2023 | Direct | F2 |
| transaction | MMSI | Common Stock, No Par Value | Sale | -$104K | -1.48K | -0.15% | $70.17 | 1.01M | Mar 1, 2023 | Direct | F3 |
| transaction | MMSI | Common Stock, No Par Value | Sale | -$1.34M | -19.2K | -1.89% | $69.86 | 993K | Mar 2, 2023 | Direct | F4 |
| holding | MMSI | Common Stock, No Par Value | 96.8K | Feb 28, 2023 | By 401(k) Plan | F5 | |||||
| holding | MMSI | Common Stock, No Par Value | 90 | Feb 28, 2023 | By spouse as custodian for child | F6 | |||||
| holding | MMSI | Common Stock, No Par Value | 6.89K | Feb 28, 2023 | By spouse |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MMSI | Non-qualified stock options (right to buy) | Award | $0 | +54.3K | $0.00 | 54.3K | Feb 28, 2023 | Common Stock | 54.3K | $70.58 | Direct | F7 | |
| holding | MMSI | Non-qualified stock options (right to buy) | 200K | Feb 28, 2023 | Common Stock | 200K | $28.20 | Direct | F8 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 6K | Feb 28, 2023 | Common Stock | 6K | $28.20 | By spouse | F9, F10 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 38K | Feb 28, 2023 | Common Stock | 38K | $44.80 | Direct | F11 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 4K | Feb 28, 2023 | Common Stock | 4K | $44.80 | By spouse | F10, F12 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 159K | Feb 28, 2023 | Common Stock | 159K | $55.73 | Direct | F13 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 2K | Feb 28, 2023 | Common Stock | 2K | $55.73 | By spouse | F10, F14 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 100K | Feb 28, 2023 | Common Stock | 100K | $37.71 | Direct | F15 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 58.1K | Feb 28, 2023 | Common Stock | 58.1K | $56.25 | Direct | F16 |
| Id | Content |
|---|---|
| F1 | These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.26.2020 and 03.19.2021. |
| F2 | These shares were not sold in an open-market transaction. |
| F3 | The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.44 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| F4 | The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.6 to $70.1 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| F5 | Represents plan holdings as of 01/31/2023. |
| F6 | Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse. |
| F7 | Becomes exercisable in equal annual installments of 25% commencing 02/28/2024. |
| F8 | Becomes exercisable in equal annual installments of 20% commencing 4/14/2018. |
| F9 | Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 4/14/2018. Options not vested as of 6/22/2020 have been forfeited. |
| F10 | Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse. |
| F11 | Becomes exercisable in equal annual installments of 20% commencing 3/2/2019. |
| F12 | Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/2/2019. Options not vested as of 6/22/2020 have been forfeited. |
| F13 | Becomes exercisable in equal annual installments of 20% commencing 3/1/2020. |
| F14 | Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited. |
| F15 | Becomes exercisable in equal annual installments of 25% commencing 2/26/2021. |
| F16 | Becomes exercisable in equal annual installments of 25% commencing 3/19/2022. |